Full Length Research Paper
References
|
Abdelbary G (2011). Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm. Dev. Technol. 16:44-56. Crossref |
||||
|
Allen TM, Cullis PR (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 65:36-48. Crossref |
||||
|
Barbosa RM, Luna Finkler CL, Bentley MV, Santana MH (2013). Physicochemical characterization of surfactant incorporating vesicles that incorporate colloidal magnetite. J. Liposome Res. 23:47-53. Crossref |
||||
|
Boinpally RR, Zhou SL, Poondru S, Devraj G, Jasti BR (2003). Lecithin vesicles for topical delivery of diclofenac, Eur. J. Pharm. Biopharm. 56:389–92. Crossref |
||||
|
Bouwstra JA, Gooris GS, Dubbelaar FER, Ponec M (1999). Cholesterol sulfate and calcium affect stratum corneum lipid organization over a wide temperature range. J. Lipid Res. 40:2303-12. Pubmed |
||||
|
Brown MB, Martin GP, Jones SA, Akomeah FK (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 13:175-87. Crossref |
||||
|
Bruinsma R (1996). Rheology and shape transitions of vesicles under capillary flow. Physica A 234:249-70. Crossref |
||||
|
Cereda CM, Franz-Montan M, Da Silva CM, Casadei BR, Domingue CC, Tofoli GR, De Araujo DR, De Paula E (2013). Transdermal delivery of butamben using elastic and conventional liposomes. J Liposome Res. 23:228-34. Crossref |
||||
| Cevc G (1995). Handbook of Biological Physics. Material transport across permeability barriers by means of lipid vesicles. Chapter 9. | ||||
|
Cevc G (1996). Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13:257-388. Crossref |
||||
|
Cevc G (1997). Drug delivery across the skin. Expert Opin Investig. Drugs 6:1887-937. Crossref |
||||
|
Cevc G (2012). Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy. J. Control. Release 160: 135-46. Crossref |
||||
|
Cevc G, Blume G (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta. 1104:226-32. Crossref |
||||
|
Cevc G, Blume G (2001). New highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta. 1514:191-205. Crossref |
||||
|
Cevc G, Blume G (2004). Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim. Biophys. Acta-Biomembranes 1663:61-73. Crossref |
||||
|
Cevc G, Schatzlein A, Richardsen H (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim. Biophys. Acta Biomembranes 1564:21-30. Crossref |
||||
|
Cevc G, Gebauer D (2003). Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys. J. 84:1010-24. Crossref |
||||
|
Chen J, Lu WL, Gu W, Lu SS, Chen ZP, Cai BC (2013). Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin. Drug Deliv. 10:845-56. Crossref |
||||
|
Chen J, Yan GJ, Hu RR, Gu QW, Chen ML, Gu W, Chen ZP, Cai BC (2012). Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine. Int. J. Nanomed. 7:3567-77. Crossref |
||||
|
Chen PS, Toriba TY, Warner H (1956). Microdetermination of phosphorus. Anal. Chem. 28:1756–58. Crossref |
||||
|
Curic A, Reul R, Moschwitzer J. Fricker G (2013). Formulation optimization of itraconazole loaded PEGylated liposomes for parenteral administration by using design of experiments. Int. J. Pharm. 448:189-97. Crossref |
||||
| De Oliveira L (2007). Rheology and transition shapes of elastic liposomes in nanopores membranes. Dissertação (Mestrado), Universidade Estadual de Campinas, Faculdade de Engenharia Química. | ||||
|
El Maghraby GM, Williams AC, Barry BW (1999). Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies, J. Pharm. Pharmacol. 51:1123–34. Crossref |
||||
|
El Maghraby GM, Williams AC, Barry BW (2000). Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int. J. Pharm. 196: 63–74. Crossref |
||||
|
Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2007). PG-liposomes: novel lipid vesicles for skin delivery of drugs. J. Pharm. Pharm. 59:1447-50. Crossref |
||||
|
El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int. J. Pharm. 397:12:164–172. Crossref |
||||
| Gregoriades G, Florence AT, Patel HM (1993). Liposomes in drug delivery. Amsterdam: Harwood Academic Publishers | ||||
|
Honeywell-Nguyen PL, Frederik PM, Bomans PH, Junginger HE, Bouwstra JA (2002). Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies. Pharm. Res. 19: 991–7 Crossref |
||||
|
Honeywell-Nguyen PL, Arenja S, Bouwstra JA (2003a). Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm. Res. 20:1619-25. Crossref |
||||
|
Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA (2003b). The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J. Controll. Release 90:243–55. Crossref |
||||
|
Honeywell-Nguyen PL, Bouwstra JA (2003).The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J. Control. Release 86:145–156. Crossref |
||||
|
Huang YB, Tsai MJ, Wu PC, Tsai YH, Wu YH, Fang JY (2011). Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J. Drug Target 19:709-18. Crossref |
||||
|
Hunter DG, Frisken BJ (1998). Effect of extrusion pressure and lipid properties on the size and polydispersity of lipid vesicles. Biophys. J. 74:2996-3002. Crossref |
||||
|
Jain S, Kumar D, Swarnakar NK, Thanki K (2012). Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials 33:6758-68. Crossref |
||||
|
Lee EH, Kim A, Oh YK, Kim CK (2005). Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26(2):205-10. Crossref |
||||
|
Mezei M, Gulasekharam V (1980). Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci. 26:1473-7. Crossref |
||||
| New RRC (1990). Liposomes: a Practical Approach, New York, IRL Press. | ||||
|
Nounou MI, El-Khordagui LK, Khalafallah NA, Khalil SA (2008). Liposomal formulation for dermal and transdermal drug delivery: past, present and future. Recent Pat. Drug Deliv. Formul. 2:9-18. Crossref |
||||
|
Pierre MBR, Costa ISM (2011). Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch. Dermatol. Res. 303:607-21. Crossref |
||||
|
Prausnitz MR, Langer R (2008). Transdermal drug delivery. Nature Biotechnol. 26:1261-8. Crossref |
||||
|
Ranade VV (1989). Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers. J. Clin. Pharmacol. 29:685-94. Crossref |
||||
| Ribas AM (1997). Estudo da estabilidade de bicamadas lipidicas em presença de tensoativos. State University of Campinas. | ||||
|
Samad A, Sultana Y, Aqil M (2007). Liposomal drug delivery systems: an update review. Curr. Drug Deliv. 4:297-305. Crossref |
||||
|
Severino P, Moraes LF, Zanchetta B, Souto EB, Santana MH (2012). Elastic liposomes containing benzophenone-3 for sun protection factor enhancement. Pharm. Dev. Technol. 17:661-5. Crossref |
||||
| Slaterry J (1972). Momentum, Energy and Mass Transfer in Continua, New York, McGraw Hill. | ||||
|
Takashima Y, Tsuchiya T, Iharashi Y, Kanazawa T, Okada H, Urtti A (2012). Non-invasive ophthalmic liposomes for nucleic acid delivery to posterior segment of eye. Yakugaku Zasshi 132:1365-70. Crossref |
||||
|
Teixeira Z, Zanchetta B, Melo BA, Oliveira LL, Santana MH, Paredes-Gamero EJ, Justo GZ, Nader HB, Guterres SS, Durán N (2010). Retinyl palmitate flexible polymeric nanocapsules: characterization and permeation studies. Colloids Surf B: Biointerfaces. 81:374-80. Crossref |
||||
| Torchilin VP, Weissig V (2003). Lipossomes: a practical approach. New York: Oxford University Press. | ||||
|
Trotta M, Peira E, Debernardi F, Gallarate M (2002). Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharm. 241:319-27. Crossref |
||||
|
Trotta M, Peira E, Debernardi F, Gallarate M (2004). Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm. 270:119–25. Crossref |
||||
|
Uchino T, Lefeber F, Gooris G, Bouwstra J (2011). Physicochemical characterization of drug-loaded rigid and elastic vesicles. Int. J. Pharm. 412:142-7. Crossref |
||||
|
van Den Bergh BA, Bouwstra JA, Junginger HE, Wertz PW (1999a). Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Control Release 62:367-79. Crossref |
||||
|
van Den Bergh BA, Vroom J, Gerritsen H, Junginger HE, Bouwstra JA (1999b). Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim. Biophys. Acta 1461:155-73. Crossref |
||||
|
van Den Bergh BA, Bouwstra JA, Junginger H, Wertz P (1999c). Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Control Release 62:367–379. Crossref |
||||
|
Van Den Bergh BA,Wertz PW, Junginger HE, Bouwstra JA (2001). Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int. J. Pharm. 217:13-24. Crossref |
||||
| van Smeden J, Janssens M, Lavrijsen AP, Kezic S, Vreeken RJ, Bouwstra JA (2013a). Skin barrier dysfunction in non-lesional atopic eczema: the role of stratum corneum lipids. Eur. J. Dermatol. 23:39-42. | ||||
| Van Smeden J, Janssens M, Vreeken R, Lavrijsen A, Bouwstra JA (2013b). Free fatty acids and lipid chain length correlate with the impaired skin barrier of atopic eczema patients. J. Investigative Dermatol. 133:S123-S123. | ||||
|
Wagner A, Vorauer-Uhl K (2011). Liposome technology for industrial purposes. J. Drug Deliv. 591325. Pubmed |
||||
|
Yang Z, Lu A, Wong BC, Chen X, Bian Z, Zhao Z, Huang W, Zhang G, Chen H, Xu M (2013). Effect of Liposomes on the Absorption of Water-Soluble Active Pharmaceutical Ingredients Via Oral Administration. Curr Pharm Des. Crossref |
||||
|
Zanchetta B (2009), Liposomal nanoestruturated system containg chalcone CH8 for the cutaneous leishmaniasis treatment. Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Engenharia Química. Pubmed |
||||
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
